{"id":55116,"date":"2023-03-23T06:03:46","date_gmt":"2023-03-23T05:03:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/"},"modified":"2023-03-23T06:03:46","modified_gmt":"2023-03-23T05:03:46","slug":"norges-bank-terminates-its-observation-on-kirin-holdings","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/","title":{"rendered":"Norges Bank Terminates Its Observation On Kirin Holdings"},"content":{"rendered":"
\n

TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) today announces that Norges Bank has terminated its observation on Kirin Holdings on March 22 2023, recognizing the completion of the Myanmar business transfer.\n<\/p>\n

<\/a><\/p>\n

\n1. Background<\/b>\n<\/p>\n

\nBased on a recommendation of Norway\u2019s Council on Ethics*1<\/sup>, Norges Bank placed Kirin Holdings under observation with the possibility of exclusion from its Government Pension Fund Global in March 2021*2<\/sup>. Following Kirin Holdings\u2019 decision on the withdrawal from the Myanmar business in February 2022 and the basic agreement on the share transfer of the local joint venture Myanmar Brewery Limited in June 2022, Kirin Holdings announced the completion of the share transfer on January 23, 2023*3<\/sup>. Again, based on the recommendation of the Council on Ethics*4<\/sup>, Norges Bank terminated its observation on Kirin Holdings on March 22 2023*5<\/sup>.\n<\/p>\n

\nIn addition, the following measures have been agreed upon to take to ensure the treatment of local employees.\n<\/p>\n

\n(1) Ensure freedom of choice in regards to employment
\n
(2) Prohibition of disadvantageous changes in salary and other treatment for one year
\n
(3) Provision equivalent to three months’ salary for Myanmar employees (already disbursed prior to the share transfer)\n<\/p>\n\n\n\n\n\n\n\n\n\n
\n

\n*1\n<\/p>\n<\/td>\n

\n

\nSee Council on Ethics release dated June 23, 2020, \u201cRecommendation to place Kirin Holdings Co Ltd under observation\u201d\n<\/p>\n<\/td>\n<\/tr>\n

<\/td>\n\n

\n(https:\/\/files.nettsteder.regjeringen.no\/wpuploads01\/blogs.dir\/275\/files\/2021\/03\/Rec-Kirin-Observation-ENG.pdf<\/a><\/span>)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n*2\n<\/p>\n<\/td>\n

\n

\nSee Norges Bank release dated March 3, 2020, \u201cDecisions on observation and exclusion\u201d\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(https:\/\/www.nbim.no\/en\/the-fund\/news-list\/2021\/decisions-on-observation-and-exclusion\/<\/a><\/span>)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n*3\n<\/p>\n<\/td>\n

\n

\nSee Kirin Holdings release dated January 23, 2023, “(Progress of disclosed matters) Completion of Myanmar Brewery Limited Share Transfer”\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\n

\n(https:\/\/info.kirinholdings.com\/down.php?attach_id=11&otype=1<\/a>)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n*4\n<\/p>\n<\/td>\n

\n

\nSee Council on Ethics release dated March 22, 2023, (https:\/\/etikkradet.no\/kirin-eng\/<\/a>)<\/span>\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n*5\n<\/p>\n<\/td>\n

\n

\nSee Norges Bank release dated March 22, 2023, \u201cDecisions on observation\u201d (https:\/\/www.nbim.no\/en\/the-fund\/news-list\/2023\/decisions-on-observation\/<\/a><\/span>)\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n2. Kirin Group’s Human Rights Policy<\/b>\n<\/p>\n

\nIn accordance with the Guiding Principles on Business and Human Rights, endorsed by the United Nations Human Rights Council in 2011, Kirin Holdings created the Kirin Group Human Rights Policy in 2018.
\n
The Kirin Group has expanded its business from Food & Beverage, Pharmaceuticals, and Health Science, and its business activities have spread around the world. Respect for human rights is a foundation for all of Kirin Group business activities. The Kirin Group conducts its business activities in line with this Kirin Group Human Rights Policy.
\n
[Reference] Kirin Group’s Human Rights Policy
\n
https:\/\/www.kirinholdings.com\/en\/impact\/community\/2_1\/policies\/<\/a>\n<\/p>\n

\nAbout Kirin Holdings<\/span><\/b>\n<\/p>\n

\nKirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe.\n<\/p>\n

\nKirin Holdings can trace its roots to Japan Brewery<\/b> which was established in 1885. Japan Brewery became Kirin Brewery<\/b> in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain.\n<\/p>\n

\nUnder the Kirin Group Vision 2027<\/a><\/i><\/span> (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become \u201cA global leader in CSV*, creating value across our world of Food & Beverages to Pharmaceuticals.\u201d Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.\n<\/p>\n

\n* Creating Shared Value: combined added value for consumers as well as for society at large\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPress Contact
\n
Corporate Communication Department, Kirin Holdings Company, Limited
\n
Nakano Central Park South, 4-10-2 Nakano, Nakano-ku, Tokyo
\n
+81-3-6837-7028
\n
https:\/\/www.kirinholdings.com\/en\/<\/a>
kirin-cc@kirin.co.jp<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) today announces that Norges Bank has terminated its observation on Kirin Holdings on March 22 2023, recognizing the completion of the Myanmar business transfer. 1. Background Based on a recommendation of Norway\u2019s Council on Ethics*1, Norges Bank placed Kirin Holdings under observation with the possibility of exclusion from … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55116","6":"format-standard","7":"category-industry"},"yoast_head":"\nNorges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Norges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) today announces that Norges Bank has terminated its observation on Kirin Holdings on March 22 2023, recognizing the completion of the Myanmar business transfer. 1. Background Based on a recommendation of Norway\u2019s Council on Ethics*1, Norges Bank placed Kirin Holdings under observation with the possibility of exclusion from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-23T05:03:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Norges Bank Terminates Its Observation On Kirin Holdings\",\"datePublished\":\"2023-03-23T05:03:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/\"},\"wordCount\":616,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230322005808\\\/en\\\/783468\\\/21\\\/new_kirin.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/\",\"name\":\"Norges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230322005808\\\/en\\\/783468\\\/21\\\/new_kirin.jpg\",\"datePublished\":\"2023-03-23T05:03:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230322005808\\\/en\\\/783468\\\/21\\\/new_kirin.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230322005808\\\/en\\\/783468\\\/21\\\/new_kirin.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/norges-bank-terminates-its-observation-on-kirin-holdings\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Norges Bank Terminates Its Observation On Kirin Holdings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Norges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/","og_locale":"en_US","og_type":"article","og_title":"Norges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend","og_description":"TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) today announces that Norges Bank has terminated its observation on Kirin Holdings on March 22 2023, recognizing the completion of the Myanmar business transfer. 1. Background Based on a recommendation of Norway\u2019s Council on Ethics*1, Norges Bank placed Kirin Holdings under observation with the possibility of exclusion from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-23T05:03:46+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Norges Bank Terminates Its Observation On Kirin Holdings","datePublished":"2023-03-23T05:03:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/"},"wordCount":616,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/","url":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/","name":"Norges Bank Terminates Its Observation On Kirin Holdings - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg","datePublished":"2023-03-23T05:03:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230322005808\/en\/783468\/21\/new_kirin.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/norges-bank-terminates-its-observation-on-kirin-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Norges Bank Terminates Its Observation On Kirin Holdings"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55116"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55116\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}